Arizona § 36-1332 Individualized investigational treatment; availability

Arizona Statutes

§ 36-1332 — Individualized investigational treatment; availability

Arizona § 36-1332

Title 36Arizona Revised Statutes

Ch. 11INDIVIDUALIZED INVESTIGATIONAL TREATMENT

Art. 1General Provisions

This text of Arizona § 36-1332 (Individualized investigational treatment; availability) is published on Counsel Stack Legal Research, covering Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ariz. Rev. Stat. Ann. § 36-1332 (2026).

Text

A.A manufacturer operating within an eligible facility and pursuant to all applicable federalwide assurance regulations may make available to an eligible patient an individualized investigational treatment. An eligible patient's physician may request an individualized investigational drug, biological product or device from an eligible facility or manufacturer operating within the eligible facility. This article does not require that a manufacturer make available an individualized investigational drug, biological product or device to an eligible patient.

B.An eligible facility or manufacturer operating within an eligible facility may do both of the following:

1.Provide an individualized investigational drug, biological product or device to an eligible patient without receiving compens

Free access — add to your briefcase to read the full text and ask questions with AI

A. A manufacturer operating within an eligible facility and pursuant to all applicable federalwide assurance regulations may make available to an eligible patient an individualized investigational treatment. An eligible patient's physician may request an individualized investigational drug, biological product or device from an eligible facility or manufacturer operating within the eligible facility. This article does not require that a manufacturer make available an individualized investigational drug, biological product or device to an eligible patient.

B. An eligible facility or manufacturer operating within an eligible facility may do both of the following:

1. Provide an individualized investigational drug, biological product or device to an eligible patient without receiving compensation.

2. Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the individualized investigational drug, biological product or device.